Holen Sie sich die Stockscreener-App
37.35
4.95%
1.715
Schlusskurs vom Vortag:
$35.63
Offen:
$36.02
24-Stunden-Volumen:
657.31K
Relative Volume:
0.26
Marktkapitalisierung:
$5.66B
Einnahmen:
$3.24B
Nettoeinkommen (Verlust:
$304.90M
KGV:
17.96
EPS:
2.08
Netto-Cashflow:
$156.70M
1W Leistung:
-10.87%
1M Leistung:
-1.79%
6M Leistung:
-37.79%
1J Leistung:
-40.69%
1-Tages-Spanne:
$35.99
$37.96
1-Wochen-Bereich:
$34.62
$42.70
52-Wochen-Spanne:
$34.10
$72.94
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Vergleichen Sie BRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
37.33 | 6.55B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
125.32 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.16 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
393.15 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.39 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.26 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
S&P 500 eyes new record, Opendoor skyrockets, Bruker plummets - Yahoo Finance
Wall Street Extends Records, Gold Rallies To $3,400: What's Moving Markets Monday? - Benzinga
Why Bruker (BRKR) Shares Are Getting Obliterated Today - Yahoo Finance
Bruker Projects Q2 Revenue Of $795M–$798M; Non-GAAP EPS Expected At $0.32–$0.34, Down $0.19 YoY Amid $0.06 FX Impact - 富途牛牛
Bruker stock plunges as Stifel maintains Hold rating amid Q2 revenue miss - Investing.com
Bruker tumbles as preliminary Q2 results show revenue decline - Investing.com
Press Release: Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025 - 富途牛牛
Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025 - Yahoo Finance
What analysts say about Bruker Corporation stockSkyrocketing returns - PrintWeekIndia
What drives Bruker Corporation stock priceDouble-digit growth - jammulinksnews.com
Bruker Corporation Stock Analysis and ForecastConsistent double returns - jammulinksnews.com
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know - Yahoo Finance
10x Genomics Ends UPC Patent Fight With Bruker - Law360
March 2026 Options Now Available For Bruker (BRKR) - Nasdaq
Bruker Corp Shares Surge 3.51% Amid Analyst Estimates and GF Value Prediction - AInvest
Rare Earth Metals concept stocks continued to rise at the start of the day, as the United States aims to accelerate the construction of the Rare Earth Metals supply chain, and the Bruker Corp Rare Earth Metals project in Wyoming has officially launched. - 富途牛牛
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection - Quantisnow
Bruker Acquires Majority Stake in RECIPE, Boosts Diagnostic and Drug Monitoring Capabilities - Yahoo Finance
Bruker: Weakness In Academic Research Shadows Near-Term Growth; Initiate With 'Hold' - Seeking Alpha
Bruker price target lowered to $50 from $61 at BofA - Yahoo Finance
BRKR: B of A Securities Updates Price Target for Bruker | BRKR Stock News - GuruFocus
Bruker (BRKR) Price Target Reduced by BofA Amid Market Uncertain - GuruFocus
AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology - Insider Monkey
Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands - Yahoo Finance
10x Genomics Settles Patent Dispute With Bruker - Insider Monkey
First Week of August 15th Options Trading For Bruker (BRKR) - Nasdaq
Bruker Corp (BRKR) Shares Up 3.22% on Jun 18 - GuruFocus
Q1 Earnings Outperformers: Bruker (NASDAQ:BRKR) And The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Ex-Dividend Reminder: DTE Energy, HCA Healthcare and Bruker - Nasdaq
Dairy Analyzer | Bruker Optics Inc. | Products - Photonics Spectra
Bruker Corp (BRKR) Trading 4.64% Higher on Jun 10 - GuruFocus
Bruker Stock Set to Gain From Acquisition of Austria's biocrates - Yahoo Finance
Bruker Leads 3 Growth Stocks With Strong Insider Ownership - Yahoo Finance
Bruker acquires Austria based biocrates - MSN
Bruker introduces new timsUltra AIP System at ASMS 2025 - SelectScience
Bruker at Jefferies Conference: Strategic Growth Amid Challenges - Investing.com
biocrates life sciences ag becomes part of Bruker Group - SelectScience
Bruker launches revolutionary timsOmni mass spectrometer at ASMS 2025 - SelectScience
New proteoElute nanoLC System and PepSep Advanced nLC Columns showcased at ASMS 2025 - SelectScience
Bruker Corporation (BRKR) Acquires Biocrates to Expand Multiomics Solutions - Insider Monkey
Bruker invests in diagnostics, unveils new analysis platform By Investing.com - Investing.com Nigeria
Bruker's New Mass Spectrometry Platform Achieves 40% Higher Detection Rate for Environmental Contaminants - Stock Titan
Bruker (BRKR) Acquires Biocrates to Boost Metabolomics Solutions - GuruFocus
Should You Invest in Bruker Corp (BRKR)? - Insider Monkey
Bruker expands multiomics with biocrates acquisition - Investing.com
Bruker expands multiomics with biocrates acquisition By Investing.com - Investing.com Canada
Bruker (BRKR) Expands with Biocrates Life Sciences Acquisition | BRKR Stock News - GuruFocus
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics - Quantisnow
Bruker unveils new mass spectrometer with enhanced sensitivity By Investing.com - Investing.com South Africa
Bruker (BRKR) Unveils Advanced Mass Spectrometer for 4D-Proteomics | BRKR Stock News - GuruFocus
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ORNELL JOHN A | Director |
May 13 '25 |
Option Exercise |
18.15 |
5,000 |
90,750 |
31,445 |
| LINTON WILLIAM A | Director |
Apr 22 '25 |
Option Exercise |
24.00 |
10,000 |
240,000 |
58,723 |
| Bures Thomas | Chief Accounting Officer |
Mar 10 '25 |
Buy |
47.40 |
500 |
23,698 |
3,472 |
| LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
0.66%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):